Nos publications
GELUCIRE® 4414 for type IV lipid based formulations and their in vitro in vivo performance evaluation
AAPS PharmSci360 – Philadelphia (USA) - 2021
In this study, Gelucire® 44/14 in type IV lipid-based formulation has been evaluated to increase the solubility and in vivo performance of ticagrelor.